Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of data-driven clusters in diabetes-free adults and their utility for risk stratification of type 2 diabetes.
Yacamán Méndez D, Zhou M, Trolle Lagerros Y, Gómez Velasco DV, Tynelius P, Gudjonsdottir H, Ponce de Leon A, Eeg-Olofsson K, Östenson CG, Brynedal B, Aguilar Salinas CA, Ebbevi D, Lager A. Yacamán Méndez D, et al. Among authors: gomez velasco dv. BMC Med. 2022 Oct 18;20(1):356. doi: 10.1186/s12916-022-02551-6. BMC Med. 2022. PMID: 36253773 Free PMC article.
Non-Nutritive Sweeteners: Evidence on their Association with Metabolic Diseases and Potential Effects on Glucose Metabolism and Appetite.
Romo-Romo A, Aguilar-Salinas CA, Gómez-Díaz RA, Brito-Córdova GX, Gómez-Velasco DV, López-Rocha MJ, Almeda-Valdés P. Romo-Romo A, et al. Among authors: gomez velasco dv, gomez diaz ra. Rev Invest Clin. 2017 May-Jun;69(3):129-138. doi: 10.24875/ric.17002141. Rev Invest Clin. 2017. PMID: 28613282 Free article. Review.
Mexican Carriers of the HNF1A p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas.
Martagón AJ, Bello-Chavolla OY, Arellano-Campos O, Almeda-Valdés P, Walford GA, Cruz-Bautista I, Gómez-Velasco DV, Mehta R, Muñoz-Hernández L, Sevilla-González M, Viveros-Ruiz TL, Ordoñez-Sánchez ML, Rodríguez-Guillen R, Florez JC, Tusié-Luna MT, Aguilar-Salinas CA; Slim Initiative in Genomic Medicine for the Americas (SIGMA) Type 2 Diabetes Consortium. Martagón AJ, et al. Among authors: gomez velasco dv. Diabetes Care. 2018 Aug;41(8):1726-1731. doi: 10.2337/dc18-0384. Epub 2018 May 29. Diabetes Care. 2018. PMID: 29844095
Identification of a threshold to discriminate fasting hypertriglyceridemia with postprandial values.
Sevilla-González MDR, Aguilar-Salinas CA, Muñóz-Hernández L, Almeda-Valdés P, Mehta R, Zubirán R, Bello-Chavolla OY, Gómez-Velasco DV, Vargas-Vázquez A, Viveros-Ruíz T, Martagón-Rosado AJ, Cruz-Bautista I. Sevilla-González MDR, et al. Among authors: gomez velasco dv. Lipids Health Dis. 2018 Jul 18;17(1):156. doi: 10.1186/s12944-018-0803-8. Lipids Health Dis. 2018. PMID: 30021651 Free PMC article.
The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes.
Almeda-Valdes P, Gómez Velasco DV, Arellano Campos O, Bello-Chavolla OY, Del Rocío Sevilla-González M, Viveros Ruiz T, Martagón Rosado AJ, Bautista CJ, Muñoz Hernandez L, Cruz-Bautista I, Moreno-Macias H, Huerta-Chagoya A, Rodríguez-Álvarez KG, Walford GA, Jacobs SBR, Guillen Pineda LE, Ordoñez-Sánchez ML, Roldan-Valadez E, Azpiroz J, Furuzawa-Carballeda J, Clark P, Herrera-Hernández MF, Zambrano E, Florez JC, Tusié Luna MT, Aguilar-Salinas CA. Almeda-Valdes P, et al. Among authors: gomez velasco dv. Eur J Endocrinol. 2019 Feb 1;180(2):99-107. doi: 10.1530/EJE-18-0677. Eur J Endocrinol. 2019. PMID: 30475225
[Development and validation of a screening score for prediabetes and undiagnosed diabetes.].
Rojas-Martínez R, Escamilla-Núñez C, Gómez-Velasco DV, Zárate-Rojas E, Aguilar-Salinas CA; Grupo colaborador de la cohorte para estimar la incidencia del síndrome metabólico; Grupo colaborador de la cohorte para estimar la incidencia del síndrome metabólico*. Rojas-Martínez R, et al. Among authors: gomez velasco dv. Salud Publica Mex. 2018 Sep-Oct;60(5):500-509. doi: 10.21149/9057. Salud Publica Mex. 2018. PMID: 30550111 Spanish.
Development and validation of a predictive model for incident type 2 diabetes in middle-aged Mexican adults: the metabolic syndrome cohort.
Arellano-Campos O, Gómez-Velasco DV, Bello-Chavolla OY, Cruz-Bautista I, Melgarejo-Hernandez MA, Muñoz-Hernandez L, Guillén LE, Garduño-Garcia JJ, Alvirde U, Ono-Yoshikawa Y, Choza-Romero R, Sauque-Reyna L, Garay-Sevilla ME, Malacara-Hernandez JM, Tusie-Luna MT, Gutierrez-Robledo LM, Gómez-Pérez FJ, Rojas R, Aguilar-Salinas CA. Arellano-Campos O, et al. Among authors: gomez velasco dv, gomez perez fj. BMC Endocr Disord. 2019 Apr 28;19(1):41. doi: 10.1186/s12902-019-0361-8. BMC Endocr Disord. 2019. PMID: 31030672 Free PMC article.
Prediction of incident hypertension and arterial stiffness using the non-insulin-based metabolic score for insulin resistance (METS-IR) index.
Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vázquez A, Martagón AJ, Mehta R, Arellano-Campos O, Gómez-Velasco DV, Almeda-Valdés P, Cruz-Bautista I, Melgarejo-Hernandez MA, Muñoz-Hernandez L, Guillén LE, Garduño-García JJ, Alvirde U, Ono-Yoshikawa Y, Choza-Romero R, Sauque-Reyna L, Garay-Sevilla ME, Malacara-Hernandez JM, Tusié-Luna MT, Gutierrez-Robledo LM, Gómez-Pérez FJ, Rojas R, Aguilar-Salinas CA. Bello-Chavolla OY, et al. Among authors: gomez velasco dv, gomez perez fj. J Clin Hypertens (Greenwich). 2019 Aug;21(8):1063-1070. doi: 10.1111/jch.13614. Epub 2019 Jul 18. J Clin Hypertens (Greenwich). 2019. PMID: 31318156 Free PMC article.
Empowerment of patients with type 2 diabetes: current perspectives.
Gómez-Velasco DV, Almeda-Valdes P, Martagón AJ, Galán-Ramírez GA, Aguilar-Salinas CA. Gómez-Velasco DV, et al. Diabetes Metab Syndr Obes. 2019 Aug 6;12:1311-1321. doi: 10.2147/DMSO.S174910. eCollection 2019. Diabetes Metab Syndr Obes. 2019. PMID: 31496769 Free PMC article.
20 results